Arrhythmogenic cardiomyopathy is a rare disease. Nonetheless, it is one of the leading causes of sudden cardiac death, particularly in young athletes ≤35 years of age.
The aim of this short review is to summarise the assessment of tricuspid regurgitation and to show new transcatheter therapeutic options.
One of the true epochal successes of modern medicine was the development of percutaneous treatment of coronary artery disease.
A reason for persistence in research and organ donation programmes.
Delay in the left-sided conduction system after TAVI masks right bundle-branch block.
Incomplete stent apposition of a Magmaris bioresorbable scaffold.
A platform for postgraduate education and scientific work.
EMH on Facebook
Newsletter for advertisers
Cardiovascular MedicineEMH Swiss Medical Publishers Ltd.Farnsburgerstrasse 8CH-4132 MuttenzTel. +41 (0)61 467 85 55Fax +41 (0)61 467 85 56e-mail: Editorial office
EMH MediaSchweizerische ÄrztezeitungSwiss Medical ForumSwiss Medical WeeklyPrimary and Hospital CareSwiss Archives of Neurology, Psychiatry and PsychotherapySynapseSwiss Medical Informatics